Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Gentamicin is a potent aminoglycoside antibiotic used to treat serious bacterial infections. It works by inhibiting protein synthesis in susceptible Gram-negative bacteria and certain Gram-positive organisms.
Name
Gentamicin
Raw Name
GENTAMICIN SULFATE
Category
Other
Salt Form
Sulfate
Drug Count
6
Variant Count
49
Last Verified
February 17, 2026
RxCUI
310467, 313996, 1870676, 197736, 242816, 310473, 310477, 1870631, 1870633, 1870650, 310465, 197735, 310466, 545236
UNII
8X7386QRLV
About Gentamicin
Gentamicin is a potent aminoglycoside antibiotic used to treat serious bacterial infections. It works by inhibiting protein synthesis in susceptible Gram-negative bacteria and certain Gram-positive organisms.
Detailed information about Gentamicin
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Gentamicin.
Gentamicin exerts its bactericidal (bacteria-killing) effect by inhibiting bacterial protein synthesis. At the molecular level, Gentamicin molecules pass through the outer membrane of Gram-negative bacteria via porin channels. Once inside the periplasmic space, the drug is actively transported across the inner cytoplasmic membrane in an oxygen-dependent process. This is why aminoglycosides like Gentamicin are generally ineffective against anaerobic bacteria (bacteria that grow without oxygen).
Inside the bacterial cell, Gentamicin binds irreversibly to the 30S subunit of the bacterial ribosome. Specifically, it targets the A-site of the 16S rRNA. This binding has three primary effects: it interferes with the initiation complex of protein formation, it induces the misreading of the genetic code (mRNA), leading to the synthesis of nonfunctional or toxic proteins, and it causes the breakup of polysomes into nonfunctional monosomes. The accumulation of these abnormal proteins within the bacterial cell membrane eventually leads to increased membrane permeability and cell death. Unlike many other antibiotics that only inhibit growth (bacteriostatic), Gentamicin is rapidly bactericidal, particularly in a concentration-dependent manner.
Understanding the pharmacokinetics of Gentamicin is crucial for ensuring efficacy while minimizing toxicity.
Gentamicin is indicated for the treatment of serious infections caused by susceptible strains of microorganisms. These include:
Gentamicin is available in several formulations to target different types of infections:
> Important: Only your healthcare provider can determine if Gentamicin is right for your specific condition. Because of its potential for toxicity, it is typically reserved for serious infections where the benefits outweigh the risks.
The dosage of Gentamicin is highly individualized based on the patient's body weight, renal function, and the severity of the infection. Healthcare providers typically use one of two dosing strategies: traditional multiple-daily dosing or extended-interval (once-daily) dosing.
Gentamicin is used in pediatric patients, including neonates, but dosing is specialized due to differences in kidney development and body water composition.
Because Gentamicin is cleared almost exclusively by the kidneys, dose adjustments are mandatory for patients with impaired renal function. Doctors will typically measure the creatinine clearance (CrCl) and either increase the interval between doses or decrease the dose amount. In patients on hemodialysis, a supplemental dose is usually given after each dialysis session because the drug is removed by the procedure.
No specific dose adjustments are required for patients with liver disease, as Gentamicin is not metabolized by the liver. However, these patients should still be monitored closely for overall fluid balance.
Older adults often have a natural decline in kidney function that may not be fully reflected in serum creatinine levels. Healthcare providers will often calculate the estimated glomerular filtration rate (eGFR) and use lower doses or longer intervals to prevent accumulation and toxicity.
Gentamicin is usually administered in a hospital or clinical setting. If you are receiving Gentamicin at home through an outpatient parenteral antimicrobial therapy (OPAT) program, follow these instructions:
If you miss a dose, contact your healthcare provider or infusion nurse immediately. Do not double the dose to catch up. Timely administration is critical for both the effectiveness of the drug and the prevention of toxicity.
Signs of a Gentamicin overdose may include sudden hearing loss, dizziness, loss of balance, or a significant decrease in urination. In the event of a suspected overdose, emergency measures include hemodialysis, which can efficiently remove Gentamicin from the blood. Peritoneal dialysis is less effective but can be used if hemodialysis is unavailable.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Regular blood tests to monitor drug levels (therapeutic drug monitoring) are a standard part of Gentamicin therapy.
While Gentamicin is life-saving, it is associated with several common side effects, particularly when used for more than a few days. Common reactions include:
> Warning: Stop taking Gentamicin and call your doctor immediately if you experience any of these serious symptoms.
Prolonged use of Gentamicin (typically more than 10 to 14 days) significantly increases the risk of cumulative toxicity. The most concerning long-term effect is permanent damage to the hair cells in the inner ear, which can result in irreversible deafness. Additionally, chronic kidney damage may occur, although the kidneys have a greater capacity for recovery compared to the inner ear. Patients who require long-term therapy must undergo regular audiograms (hearing tests) and kidney function monitoring.
The FDA has issued several boxed warnings for Gentamicin due to its potential for severe toxicity:
Report any unusual symptoms to your healthcare provider immediately. Early detection of toxicity is the only way to prevent permanent damage.
Gentamicin is a high-alert medication. It must be used with extreme caution and only under the supervision of a healthcare professional experienced in managing aminoglycoside therapy. Patients must remain well-hydrated during treatment to help the kidneys flush the drug out of the system and reduce the risk of tubular damage.
Nephrotoxicity: Gentamicin can cause significant kidney damage. Risk factors include pre-existing renal impairment, advanced age, and dehydration. Monitoring of renal function (BUN and creatinine) is required.
Ototoxicity: This drug is toxic to the organs of hearing and balance. Hearing loss can be permanent and may not be noticed until after treatment ends. Vestibular toxicity (dizziness/vertigo) is also a major risk.
Neuromuscular Blockade: Gentamicin can cause muscle weakness and respiratory failure. Caution is needed in patients with myasthenia gravis or Parkinson's disease.
Pregnancy: There is evidence of human fetal risk (deafness) based on data from aminoglycoside use during pregnancy.
To ensure safety, your healthcare team will perform the following tests:
Gentamicin can cause dizziness, vertigo, and blurred vision. You should not drive or operate heavy machinery until you know how the medication affects you and your balance.
While there is no direct chemical interaction between Gentamicin and alcohol, alcohol can lead to dehydration. Since dehydration is a major risk factor for Gentamicin-induced kidney damage, it is generally advised to avoid alcohol during treatment.
Gentamicin does not typically require a tapering schedule. However, it should only be stopped under the direction of a doctor. If the drug is stopped because of early signs of ear or kidney toxicity, your doctor will monitor those organs closely for weeks after the last dose, as damage can sometimes progress after the drug is gone.
> Important: Discuss all your medical conditions with your healthcare provider before starting Gentamicin, especially any history of kidney disease or hearing problems.
Certain medications should never be used concurrently with Gentamicin due to an extreme risk of additive toxicity:
For each major interaction, the mechanism is usually either pharmacodynamic (additive toxic effects on the same organ) or pharmacokinetic (competition for renal excretion). The clinical consequence is almost always an increased risk of permanent ear or kidney damage. Management involves avoiding the combination, adjusting doses, or increasing the frequency of blood tests.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Gentamicin must NEVER be used in the following circumstances:
In these situations, the healthcare provider will perform a careful risk-benefit analysis:
Patients should be aware that cross-sensitivity exists among the aminoglycoside class. This includes:
If you have had a skin rash or breathing problems after using a neomycin-containing triple antibiotic ointment (like Neosporin), you must inform your doctor, as this could indicate a potential allergy to systemic Gentamicin.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Gentamicin. Always disclose any history of kidney, hearing, or nerve disorders.
Gentamicin is classified as FDA Pregnancy Category D. This means there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience. Aminoglycosides cross the placenta and can accumulate in the fetal kidneys and inner ear. There have been documented cases of total, irreversible, bilateral congenital deafness in children whose mothers received streptomycin (a related aminoglycoside) during pregnancy. While Gentamicin is sometimes used in life-threatening maternal infections where no other option exists, the risk to the fetus is substantial. It should not be used for minor infections during pregnancy.
Gentamicin is excreted into human breast milk in small amounts. However, aminoglycosides are poorly absorbed from the gastrointestinal tract. Therefore, the nursing infant is unlikely to absorb significant amounts of the drug into their bloodstream. The primary risk to the infant is the potential for Gentamicin to alter the natural bacterial flora in the gut, leading to diarrhea or thrush. The American Academy of Pediatrics considers Gentamicin to be generally compatible with breastfeeding, but the infant should be monitored for digestive issues.
Gentamicin is approved for use in children and neonates. In fact, it is a standard component of the "rule-out sepsis" protocol in newborn nurseries. However, because neonatal kidneys are immature, the drug's half-life is much longer in newborns than in older children. Pediatric dosing must be calculated precisely based on weight and age, and blood level monitoring is mandatory to prevent toxicity that could lead to lifelong hearing impairment.
Patients over the age of 65 are at the highest risk for Gentamicin-induced toxicities. This is due to the natural age-related decline in glomerular filtration rate (GFR). Elderly patients are also more likely to be taking other nephrotoxic medications (like NSAIDs for arthritis) or have conditions like diabetes that predispose them to kidney injury. In this population, "normal" serum creatinine levels can be misleading, and doctors must use calculated creatinine clearance to determine the safe dose.
In patients with renal impairment, the elimination of Gentamicin is significantly delayed. If the dose is not adjusted, the drug will accumulate to toxic levels. For patients with a GFR below 60 mL/min, the dosing interval is typically extended (e.g., from every 8 hours to every 12 or 24 hours). For those on dialysis, Gentamicin is removed by the dialysis membrane; therefore, the drug is usually administered immediately after the dialysis session to ensure therapeutic levels are maintained until the next session.
Since Gentamicin is not processed by the liver, no specific dose adjustments are required for patients with cirrhosis or hepatitis. However, these patients often have complex fluid balance issues (like ascites) which can change the volume of distribution for the drug, potentially requiring more frequent blood level monitoring.
> Important: Special populations require individualized medical assessment. Always ensure your doctor is aware of your age, pregnancy status, and any history of kidney disease.
Gentamicin is a bactericidal antibiotic that acts by inhibiting protein synthesis. It enters the bacterial cell through an active transport mechanism that requires oxygen. Once inside, it binds to the 30S ribosomal subunit, specifically at the 16S rRNA site. This binding causes a conformational change in the A-site of the ribosome, which leads to the misreading of mRNA codons. As a result, the wrong amino acids are inserted into the growing polypeptide chain, creating "nonsense proteins." These defective proteins are often inserted into the bacterial cell membrane, which compromises the membrane's integrity and leads to the leakage of intracellular contents and eventual cell lysis. Gentamicin also prevents the translocation of the ribosome along the mRNA strand, effectively halting all protein production.
Gentamicin exhibits concentration-dependent killing, meaning that the higher the concentration of the drug (relative to the Minimum Inhibitory Concentration or MIC of the bacteria), the faster and more complete the bacterial kill. This is the rationale behind once-daily (extended-interval) dosing. Additionally, Gentamicin possesses a significant post-antibiotic effect (PAE). This means that the drug continues to suppress bacterial growth even after the serum levels have fallen below the MIC. The PAE for Gentamicin can last for several hours, providing a safety margin when levels are low.
| Parameter | Value |
|---|---|
| Bioavailability | <1% (Oral); 100% (IM/IV) |
| Protein Binding | <10% |
| Half-life | 2-3 hours (Normal renal function) |
| Tmax | 30-90 minutes (IM) |
| Metabolism | None |
| Excretion | Renal (>90% unchanged) |
Gentamicin is classified as an aminoglycoside. It is therapeutically categorized as a narrow-spectrum antibiotic (targeting primarily aerobic Gram-negative bacilli). It is related to other aminoglycosides such as tobramycin, amikacin, and neomycin, all of which share the potential for oto- and nephrotoxicity.
Medications containing this ingredient
Common questions about Gentamicin
Gentamicin is a powerful antibiotic used to treat serious, often life-threatening bacterial infections caused by Gram-negative bacteria. Your doctor may prescribe it for conditions such as septicemia (blood poisoning), severe urinary tract infections, and infections of the lungs, bones, or abdomen. It is also used in combination with other antibiotics to treat endocarditis, an infection of the heart valves. Because of its potential for side effects, it is usually reserved for infections that are resistant to safer antibiotics. It is typically administered in a hospital setting through an IV or an injection.
The most common side effects of Gentamicin include nausea, vomiting, and upset stomach. Some patients may also experience pain or redness at the site where the injection was given. However, the most significant concerns are its 'hidden' side effects, such as damage to the kidneys and the inner ear. You may not feel kidney damage occurring, which is why doctors perform frequent blood tests. If you notice ringing in your ears, dizziness, or a decrease in how much you urinate, you must tell your medical team immediately.
It is generally recommended to avoid alcohol while being treated with Gentamicin. While alcohol does not have a direct chemical interaction with the drug, it can lead to dehydration. Dehydration is a major risk factor for Gentamicin-induced kidney damage because it causes the drug to become more concentrated in the renal tubules. Furthermore, Gentamicin is used for very serious infections, and alcohol can interfere with your body's ability to recover and fight the infection. Always consult your doctor about your lifestyle choices during antibiotic therapy.
Gentamicin is generally not considered safe during pregnancy unless the mother's life is at risk and no other antibiotics are effective. It is classified as FDA Pregnancy Category D, meaning there is clear evidence that it can harm a developing fetus. The drug can cross the placenta and cause permanent damage to the baby's inner ear, potentially leading to congenital deafness. If you are pregnant or planning to become pregnant, you must inform your doctor before starting this medication. They will weigh the risks to the baby against the severity of your infection.
Gentamicin begins working against bacteria almost immediately after it enters the bloodstream. Because it is a bactericidal antibiotic, it starts killing susceptible bacteria within the first hour of administration. However, you may not feel a significant improvement in your symptoms for 24 to 48 hours. The total length of treatment depends on the type and severity of your infection, but most courses last between 7 and 10 days. It is crucial to complete the entire course as prescribed by your healthcare provider to ensure the infection is fully eradicated.
You should never stop taking Gentamicin or any antibiotic suddenly without consulting your doctor. Stopping the medication early can allow the remaining bacteria to multiply, leading to a relapse of the infection. Furthermore, incomplete treatment contributes to the development of antibiotic resistance, making future infections harder to treat. If you are experiencing side effects like ringing in the ears or dizziness, your doctor may decide to stop the drug immediately to prevent permanent damage, but this decision must be made by a medical professional.
If you miss a dose of Gentamicin, contact your healthcare provider or the clinic where you receive your treatment immediately. Because Gentamicin levels must be carefully maintained in the blood to be effective and safe, timing is very important. Do not attempt to 'double up' on your next dose to make up for the missed one, as this can significantly increase the risk of toxicity to your kidneys and ears. Your doctor will provide instructions on when to receive your next dose based on your specific treatment schedule.
Gentamicin is not known to cause weight gain. In fact, because common side effects include nausea and loss of appetite, some patients may experience slight weight loss during treatment. If you notice rapid weight gain or swelling in your ankles, legs, or face, this could be a sign of fluid retention caused by kidney damage (nephrotoxicity). This is a serious side effect and should be reported to your doctor immediately. It is not related to an increase in body fat but rather to how your kidneys are handling fluids.
Gentamicin can interact with many other medications, some of which can increase the risk of serious side effects. For example, taking it with certain diuretics (water pills) or other antibiotics like vancomycin can significantly increase the risk of kidney and ear damage. It can also interact with muscle relaxants used during surgery. It is vital that you provide your doctor with a complete list of all medications, vitamins, and herbal supplements you are currently taking. Your healthcare provider will monitor your blood levels closely if you must take interacting drugs.
Yes, Gentamicin sulfate is available as a generic medication in several forms, including injections, ophthalmic (eye) drops, and topical creams. Generic versions are generally more cost-effective than brand-name versions and are required by the FDA to have the same quality, strength, and purity as the original brand-name drug. Because Gentamicin is an older medication, the brand-name versions (such as Garamycin) are less commonly used today than the generic equivalents. Your hospital pharmacy or local pharmacist can provide more information on the specific generic version you are receiving.